However, the mechanisms underlying the range of phenotypes following C9orf72 deletions in mouse models remains to be elucidated24–29, and understanding this variability remains an essential step for uncovering the cellular mechanisms underlying ALS and other C9orf72-linked diseases. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.